Skip to content
IP + Technology Law
Home  »  News & Insights  »  News

Partner Brent Babcock Discusses New CRISPR IP Alliance

December 19, 2016  | Brenton R. Babcock

Partner Brent Babcock, Chair of the firm’s USPTO Trials & Post-Grant Proceedings group, was quoted in “Some Consensus in the CRISPR Patent Case,” an article published in MedCity News. The article discuses four companies founded in the CRISPR space that announced last Friday, December 16, that they had formed an IP alliance.

Read the article here

 

Related Links

Industries

News & Insights

Blog - Biotechnology
Oct 2025
New FDA Program Prioritizes Review of Certain ANDAs
On October 3, 2025, the U.S. Food and Drug Administration (FDA) unveiled a pilot prioritization program that provides for accelerated review of abbreviated new drug applications (ANDAs) for generic companies...
Blog - Medical Devices & Procedures
Oct 2025
The FDA Drops New Laboratory Test Regulations
Laboratory-developed tests (“LDTs”) are in vitro diagnostic (“IVDs”) products designed and used within a single clinical laboratory to perform high complexity testing. These tests can identify a wide range of issues...
News
Sep 2025
Mitch Hadley Featured in Bloomberg Law New York Brief Q+A
In Bloomberg Law’s New York Brief Q+A series profiling top lawyers in the New York metro area, Mitch Hadley, Managing Partner of Knobbe Martens’ New York office, shared insights into...